NTI
NEUROTECH FPO [NTI]
Healthcare · ASX Small Cap
$0.0180 +12.5%
Updated 21 Jul 2026 · Signals refresh every scan
Get alerts when NTI triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Trading above both moving averages — the trend is your friend here
- Volume surging at 4.0x normal while price climbs — real buying conviction behind this move
- Beating the Small Ords index — relative strength of 1.49, so it's outpacing the pack
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (9 quarters)
- Low P/S ratio (3.0x)
- Strong revenue growth (+4069%)
- Small-cap ($20-100M)
- Capital raise activity (1 events)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +4069% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (3.02%/day)
- Altman Z-Score grey zone (2.03, low-confidence approx)
- Penny stock risk ($0.016)
- RBA hiking (-3pts)
- Dilution risk: technical breakout with recent capital raise
- Calendar: Quarterly 4C in 12d (+5pts)
Risk Signals
- Deeply negative margins (-54%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 26% over the past year
Ask Scout AI about NTI
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Neurotech secures $3.15 million R&D tax incentive loan
NONE US FDA clears IND for NTI164
NONE Notification regarding unquoted securities - NTI
Announcement tone +3pts
Recent ASX Announcements
| 2026-07-15 | Neurotech secures $3.15 million R&D tax incentive loan PRICE SENSITIVE |
| 2026-07-13 | US FDA clears IND for NTI164 PRICE SENSITIVE |
| 2026-07-13 | Notification regarding unquoted securities - NTI |
| 2026-07-12 | Proposed issue of securities - NTI |
| 2026-07-01 | NTI secures Notices of Allowance for US patent applications PRICE SENSITIVE |
Key Metrics
$21.1M
Market Cap
2.5M
Avg Volume
4.0x
Vol Ratio
$0.01 — $0.03
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-66.3%
ROE
-54.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 75% |
| L | Leader vs Laggard | pass | RS: 14 |
| I | Institutional Sponsorship | weak | Inst: 3% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
111 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track NTI and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required